IngentaConnect Fucosyltransferase VII-positive, skin-homing T cells in the blood...

Authors: Mizukawa, Yoshiko; Takahashi, Ryo; Yamazaki, Yoshimi; Kimishima, Momoko; Shiohara, Tetsuo

Source: Experimental Dermatology, Volume 17, Number 3, March 2008 , pp. 170-176(7)

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.44 plus tax Refund Policy

Abstract:

Please cite this paper as: Fucosyltransferase VII-positive, skin-homing T cells in the blood and skin lesions of atopic dermatitis patients. Experimental Dermatology 2008; 17: 170-176. Abstract:

Patients with atopic dermatitis (AD) have an abnormally increased frequency of cutaneous lymphocyte antigen (CLA)⁺ Th2 cells responsible for local inflammation; however, this is paradoxical, given the well-recognized defective capacity of Th2 cells to migrate to the skin sites of inflammation. These discrepant observations would stem from the ambiguity of CLA⁺ T cells, because CLA does not represent the epitope required for binding to E-selectin but the epitope generated by fucosyltransferase VII (Fuc-TVII) and because skin-homing T cells are composed of three distinct subpopulations; Fuc-TVII⁺ E-selectin ligand (ESL)⁺ CLA⁻, Fuc-TVII⁺ ESL⁺ CLA⁺ and Fuc-TVII⁻ ESL⁻ CLA⁺ cells. We therefore asked which subpopulations of skin-homing Th2 cells could be increased in the blood and skin lesions of AD. We analysed the frequencies of the three subpopulations in purified CD4⁺ peripheral blood T cells from AD patients and healthy controls by immunohistochemistry and flow cytometry. The Fuc-TVII⁺ CLA⁺ or CLA⁺ ESL⁺ CCR4⁺ cells were dramatically increased in frequency not only in the blood but also in the skin lesions of AD patients and this increase was related to the severity of the clinical symptoms. Our data indicate the clinical importance of identifying skin-homing T cells with the potent capacity to migrate into the skin by analysing their Fuc-TVII expression and E-selectin binding ability in patients with AD.